The difference between valganciclovir hydrochloride tablets and Vancevi
Valganciclovir hydrochloride tablets (Valganciclovir) and Vancevir are essentially the same drug, they only differ in their naming. Specifically, Valganciclovir Hydrochloride Tablets and Valganciclovir are the international common names (INN) of this drug, while Valcyte and Valcyte are the trade names of Valganciclovir. Their main ingredients, indications, usage and dosage, and efficacy are all consistent.
Valganciclovir hydrochloride tablets are an oral prodrug for the treatment of cytomegalovirus infection. Its chemical name is 1. L-valine, -2[(2-amino-1,6-dihydro-6-oxy-9H-purin-9-yl)methoxy]-3-hydroxy-propyl ester, monohydrochloride . It is an extended nucleoside analog drug that inhibits the replication and spread of CMV by inhibiting viral DNA synthesis. Valganciclovir hydrochloride tablets are suitable for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) and the prevention of CMV infection in high-risk solid organ transplant patients. The absolute bioavailability of valganciclovir hydrochloride tablets as measured by ganciclovir is 10 times higher than that of ganciclovir capsules, which makes the drug more easily absorbed and utilized in the body.
In terms of usage and dosage, the recommended dosage of valganciclovir hydrochloride tablets/vansevir for patients with active CMV retinitis is 900 mg (two 450 mg tablets ) twice a day for 21 days. After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg once daily. For kidney transplant patients, the recommended dose is 900 mg once daily, starting within 10 days after transplantation and continuing until 200 days after transplantation.
In actual use, patients can choose to purchase Valganciclovir hydrochloride tablets or Valganciclovir according to the doctor's prescription. Both have the same pharmacological effects and therapeutic effects. When using, you should follow medical advice and use it at the correct dosage and frequency to obtain the best therapeutic effect and reduce the occurrence of adverse reactions.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)